Protocol Ledger

NCT04950114 · Phase II · TERMINATED

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Interventional Phase II clinical trial protocol NCT04950114 sponsored by Goldfinch Bio in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-07-27 Enrollment: 31 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04950114
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)31 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04950114
Protocol FieldVerified Registry Value
NCT IdentifierNCT04950114
Consolidated Lead SponsorGoldfinch Bio
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment31 participants (ACTUAL)
Registered Start Date2021-07-27
WhyStopped ClassificationStrategic / Business / Sponsor Decision

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI